Secretaría de Gobernación
CONACYT
INGER
Por favor, use este identificador para citar o enlazar este ítem: http://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17282
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.rights.licensehttp://creativecommons.org/licenses/by/4.0es_MX
dc.creatorClaudia Szlejfes_MX
dc.creatorLORENA PARRA RODRIGUEZes_MX
dc.creatorOSCAR ROSAS CARRASCOes_MX
dc.date2017-
dc.date.accessioned2021-10-26T23:46:59Z-
dc.date.available2021-10-26T23:46:59Z-
dc.identifier.urihttp://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17282-
dc.descriptionObjectives: The aims of this study were to determine the prevalence of osteosarcopenic obesity (OSO) and to investigate its association with frailty and physical performance in Mexican community-dwelling middle-aged and older women. Design: Cross-sectional analysis of a prospective cohort. Setting: The FraDySMex study, a 2-round evaluation of community-dwelling adults from 2 municipalities in Mexico City. Participants: Participants were 434 women aged 50 years or older, living in the designated area in Mexico City. Measurements: Body composition was measured with dual-energy X-ray absorptiometry and OSO was defined by the coexistence of sarcopenia, osteopenia, or osteoporosis and obesity. Information regarding demographic characteristics; comorbidities; mental status; nutritional status; and history of falls, fractures, and hospitalization was obtained from questionnaires. Objective measurements of muscle strength and function were grip strength using a hand dynamometer, 6-meter gait speed using a GAIT Rite instrumented walkway, and lower extremity functioning measured by the Short Physical Performance Battery (SPPB). Frailty was assessed using the Frailty Phenotype (Fried criteria), the Gerontopole Frailty Screening Tool (GFST), and the FRAIL scale, to build 3 logistic regression models. Results: The prevalence of OSO was 19% (n = 81). Frailty (according to the Frailty Phenotype and the GFST) and poor physical performance measured by the SPPB were independently associated with OSO, controlled by age. In the logistic regression model assessing frailty with the Frailty Phenotype, the odds ratio (95% confidence interval) for frailty was 4.86 (2.47-9.55), and for poor physical performance it was 2.11 (1.15-3.89). In the model assessing frailty with the GFST, it was 2.12 (1.10-4.11), and for poor physical performance it was 2.15 (1.18-3.92). Finally, in the model with the FRAIL scale, it was 1.69 (0.85-3.36) for frailty and 2.29 (1.27-4.15) for poor physical performance. Conclusion: OSO is a frequent condition in middle-aged and older women, and it is independently associated with frailty and poor physical performance.es_MX
dc.formatAdobe PDFes_MX
dc.languageenges_MX
dc.publisherElsevier & American Medical Directors Associationes_MX
dc.relationhttps://www.jamda.com/article/S1525-8610(17)30132-9/fulltextes_MX
dc.relation.requiresSies_MX
dc.rightsAcceso Abiertoes_MX
dc.sourceJournal of the American Medical Directos Association (1525-8610) Vol. 18 (2017)es_MX
dc.subjectMEDICINA Y CIENCIAS DE LA SALUDes_MX
dc.subjectCiencias médicases_MX
dc.subjectCiencias clínicases_MX
dc.subjectGeriatríaes_MX
dc.subjectDesordenes nutricionaleses_MX
dc.subjectObesidades_MX
dc.subjectPersonas mayoreses_MX
dc.subjectFragilidades_MX
dc.subjectAtrofia musculares_MX
dc.subjectSarcopeniaes_MX
dc.subjectOsteosarcopeniaes_MX
dc.subjectGeriatricses_MX
dc.subjectNutrition disorderses_MX
dc.subjectObesityes_MX
dc.subjectElderlyes_MX
dc.subjectFrailtyes_MX
dc.subjectMuscular atrophyes_MX
dc.titleOsteosarcopenic Obesity: Prevalence and Relation With Frailty and Physical Performance in Middle-Aged and Older Womenes_MX
dc.typeArtículoes_MX
dc.audienceResearcherses_MX
dc.creator.idCA1242305es_MX
dc.creator.idPARL860513MDFRDR04es_MX
dc.creator.idROCO750722HDFSRS05es_MX
dc.creator.nameIdentifiercaes_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
Aparece en las colecciones: 1. Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Journal of the American Medical Directos Association (1525-8610) Vol. 18 (2017).pdf521.44 kBAdobe PDFVisualizar/Abrir